SCHEMBL20182572

SCHEMBL20182572

COC(=O)C1(Oc2ccccc2C=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
LMNA P02545 2/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SRC P12931 3/20 0.41
TLR2 O60603 1/20 0.41
ERN1 O75460 1/20 0.41
TLR1 Q15399 1/20 0.41
TLR6 Q9Y2C9 1/20 0.41
KMT2A Q03164 3/20 0.40
GAA P10253 1/20 0.40
NFE2L2 Q16236 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MEN1 O00255 2/20 0.38
RAD52 P43351 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20151862 0.81 ERN1 (0.38) ALDH1A1LMNACYP2C9CYP2C19HPGD
SCHEMBL20570798 0.80 ERN1 (0.39) ALDH1A1LMNAHPGDSMN1; SMN2SRC
SCHEMBL18322562 0.80 SMN1; SMN2 (0.46) ALDH1A1LMNAPTGDR2HPGDHTT
SCHEMBL15397098 0.80 ADAM17 (0.40) ALDH1A1LMNAHPGDHTTSMN1; SMN2
SCHEMBL26123722 0.80 KMT2A (0.38) ALDH1A1LMNAHPGDHTTSMN1; SMN2
SCHEMBL26126678 0.78 HPGD (0.40) ALDH1A1LMNAHPGDHTTSMN1; SMN2
SCHEMBL20137021 0.77 KDM4E (0.39) ALDH1A1CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL2428471 0.76 ERN1 (0.40) ALDH1A1PTGDR2HPGDERN1KMT2A
SCHEMBL18322694 0.75 CYP2D6 (0.40) ALDH1A1HPGDKMT2AGAAMEN1
SCHEMBL31421785 0.75 MEN1 (0.43) ALDH1A1PTGDR2HPGDKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018093949-A1 MAGL INHIBITORS ABIDE THERAPEUTICS, INC. (US) 2018-05-24 WO disclosed